La Presse canadienneLa PresseBusiness InsiderNational PostThe Carlat Psychiatry PodcastThe Mindspace PodcastModern PsychedelicsLa Presse canadienneLa PresseBusiness InsiderNational PostThe Carlat Psychiatry PodcastThe Mindspace PodcastModern Psychedelics

Featured

International Developments

The Montreal Model is increasingly informing clinical practice, research, and professional education beyond Montreal.

United Kingdom

An NHS adaptation of the Montreal Model

CIM-KeT (CNWL–Imperial–Montreal Ketamine Therapy) adapts the Montreal Model for the UK healthcare system and is currently being piloted at the CIPPRes Clinic at Imperial College London and CNWL.

Norway

A parallel model at national scale

In 2025, Norway introduced nationwide public reimbursement for intravenous ketamine treatment for treatment-resistant depression. Its integrated approach, combining ketamine with preparation, music, and psychotherapy, has been described in peer-reviewed literature as closely resembling the Montreal Model.

Australia

Clinical education and knowledge exchange

In May 2026, Dr. Nicolas Garel delivered a two-day workshop hosted by Aurora Healthcare at Belmont Private Hospital in Brisbane, bringing together psychiatrists from across the Aurora network and drawing on his experience co-developing the Montreal Model.

In the news

  • “Le bon et le mauvais de la kétamine”

    La Presse — June 20, 2025

    Read article

  • “Les espoirs brisés de la kétamine au privé”

    La Presse — March 25, 2024

    Read article

  • “A patient who tried psychedelic therapy said hallucinations of Disney imagery 'hijacked' her experience, blaming her habit of spending 6 hours a day trading Disney pins online.”

    Business Insider — August 3, 2023

    Read article

  • “Canadian woman wanted assisted suicide for depression. Then ketamine saved her.”

    National Post — May 17, 2023

    Read article